BARONI, GIANNA
 Distribuzione geografica
Continente #
NA - Nord America 2.431
EU - Europa 2.138
AS - Asia 1.126
SA - Sud America 129
AF - Africa 38
OC - Oceania 22
Totale 5.884
Nazione #
US - Stati Uniti d'America 2.400
PL - Polonia 906
RU - Federazione Russa 570
SG - Singapore 358
CN - Cina 275
HK - Hong Kong 155
IT - Italia 148
SE - Svezia 118
VN - Vietnam 110
IE - Irlanda 108
BR - Brasile 102
KR - Corea 92
DE - Germania 70
FI - Finlandia 54
FR - Francia 52
UA - Ucraina 38
IN - India 35
GB - Regno Unito 23
AU - Australia 21
ID - Indonesia 19
CA - Canada 18
JO - Giordania 18
AR - Argentina 13
BD - Bangladesh 12
JP - Giappone 10
NL - Olanda 10
TR - Turchia 10
CH - Svizzera 9
ES - Italia 9
IQ - Iraq 9
MX - Messico 9
CI - Costa d'Avorio 8
BE - Belgio 6
LT - Lituania 6
MA - Marocco 6
ZA - Sudafrica 5
AT - Austria 4
NG - Nigeria 4
UZ - Uzbekistan 4
CL - Cile 3
EC - Ecuador 3
TN - Tunisia 3
VE - Venezuela 3
AL - Albania 2
BH - Bahrain 2
BJ - Benin 2
DK - Danimarca 2
EG - Egitto 2
KZ - Kazakistan 2
NP - Nepal 2
SA - Arabia Saudita 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BO - Bolivia 1
CG - Congo 1
CO - Colombia 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
PW - Palau 1
RE - Reunion 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SZ - Regno dello Swaziland 1
Totale 5.884
Città #
Warsaw 906
Santa Clara 520
Ashburn 285
Singapore 263
Fairfield 192
Hong Kong 127
Dublin 108
Chandler 105
Seoul 92
San Jose 90
Woodbridge 87
Seattle 84
Cambridge 76
Houston 73
Beijing 64
Jacksonville 61
Hefei 59
Ann Arbor 52
Wilmington 52
The Dalles 46
Council Bluffs 45
Buffalo 39
Florence 37
Lawrence 36
Altamura 34
Ho Chi Minh City 33
Princeton 30
Lauterbourg 29
Los Angeles 29
Helsinki 27
New York 23
Mumbai 22
Melbourne 21
Bremen 20
Boston 19
Munich 19
Medford 18
Orem 17
Dallas 16
Dong Ket 16
Paris 16
San Diego 16
Boardman 15
Hanoi 15
Jakarta 15
Shanghai 13
Moscow 12
Kent 11
Milan 11
São Paulo 10
Bern 9
Abidjan 8
Tokyo 8
Haiphong 7
Phoenix 7
Rome 7
Toronto 7
Brussels 6
Clifton 6
Da Nang 6
Norwalk 6
Redondo Beach 6
Rio de Janeiro 6
Stockholm 6
Atlanta 5
Brooklyn 5
Chennai 5
Izmir 5
Tianjin 5
Turku 5
Yubileyny 5
Abuja 4
Baghdad 4
Casablanca 4
Chicago 4
Frankfurt am Main 4
London 4
Salt Lake City 4
San Francisco 4
Amsterdam 3
Austin 3
Bengaluru 3
Cape Town 3
Charlotte 3
Denver 3
Falls Church 3
Luton 3
Manchester 3
Montreal 3
Münster 3
Verona 3
Amman 2
Bani Suwayf 2
Barcelona 2
Belo Horizonte 2
Brantford 2
Buenos Aires 2
Can Tho 2
Castelfranco Di Sopra 2
Caxias do Sul 2
Totale 4.222
Nome #
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. 390
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. 315
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 302
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 297
Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases. 269
Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix. An investigation using CDX-2 and a limited immunohistochemical panel. 254
Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients 254
LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer 243
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 202
Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer. 176
Epstein-Barr virus infection and p53 expression in HIV-related oral large B cell lymphoma 174
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. 170
Bright-Field Multiplex Immunohistochemistry Assay for Tumor Microenvironment Evaluation in Melanoma Tissues 167
CDX-2 homeobox gene expression. 165
Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis. 161
Inducible nitric oxide synthase expression in human colorectal cancer - Correlation with tumor angiogenesis 159
Protease-activated receptor-2 downregulation is associated to vitiligo lesions 159
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 156
Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy 154
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors 153
Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. 149
A Fast and Automated Melanin-bleaching Method for Histopathologic Evaluation of Pigmented Melanoma Tissues 146
Differential HLA class I subunit (A, B, C heavy chain and β2-microglobulin) expression levels in normal tissues 144
Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis 140
Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. 120
Extra-mammary Paget's disease. An HPV-correlated neoplasia? 120
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 120
Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations 117
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 115
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 110
Brightfield Multiplex Immunohistochemistry Assay for PD-L1 Evaluation in Challenging Melanoma Samples 107
HPV and p53 in urinary bladder carcinoma. 102
β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines. 92
Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis 33
Totale 5.935
Categoria #
all - tutte 15.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.788


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 18 32
2021/2022235 9 30 16 4 9 13 7 18 7 14 37 71
2022/2023539 43 106 40 37 49 91 66 18 62 4 11 12
2023/2024184 6 25 31 9 9 25 6 44 3 3 13 10
2024/20251.501 44 160 83 233 393 272 41 54 66 41 62 52
2025/20261.700 208 241 140 141 252 73 246 75 119 144 61 0
Totale 5.935